126 related articles for article (PubMed ID: 2244856)
1. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
Stiko-Rahm A; Wiman B; Hamsten A; Nilsson J
Arteriosclerosis; 1990; 10(6):1067-73. PubMed ID: 2244856
[TBL] [Abstract][Full Text] [Related]
2. Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cells.
Li XN; Grenett HE; Benza RL; Demissie S; Brown SL; Tabengwa EM; Gianturco SH; Bradley WA; Fless GM; Booyse FM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3215-23. PubMed ID: 9409314
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemic VLDL downregulates tissue plasminogen activator gene transcription through cis-repressive region(s) in the tissue plasminogen activator promoter in cultured human endothelial cells.
Tabengwa EM; Benza RL; Grenett HE; Booyse FM
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1675-81. PubMed ID: 10845888
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis.
Li XN; Koons JC; Benza RL; Parks JM; Varma VK; Bradley WA; Gianturco SH; Taylor KB; Grammer JR; Tabengwa EM; Booyse FM
Biochemistry; 1996 May; 35(19):6080-8. PubMed ID: 8634250
[TBL] [Abstract][Full Text] [Related]
5. Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells.
Grenett HE; Benza RL; Fless GM; Li XN; Davis GC; Booyse FM
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1803-9. PubMed ID: 9812921
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells.
Ren S; Lee H; Hu L; Lu L; Shen GX
J Clin Endocrinol Metab; 2002 Jan; 87(1):286-91. PubMed ID: 11788661
[TBL] [Abstract][Full Text] [Related]
7. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
Karpe F; Hellénius ML; Hamsten A
Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
[TBL] [Abstract][Full Text] [Related]
8. Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cells.
Allison BA; Nilsson L; Karpe F; Hamsten A; Eriksson P
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1354-60. PubMed ID: 10323790
[TBL] [Abstract][Full Text] [Related]
9. Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells.
Nilsson L; Banfi C; Diczfalusy U; Tremoli E; Hamsten A; Eriksson P
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1679-85. PubMed ID: 9812904
[TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia and regulation of fibrinolytic activity.
Mussoni L; Mannucci L; Sirtori M; Camera M; Maderna P; Sironi L; Tremoli E
Arterioscler Thromb; 1992 Jan; 12(1):19-27. PubMed ID: 1310024
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
[TBL] [Abstract][Full Text] [Related]
12. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
Argraves KM; Battey FD; MacCalman CD; McCrae KR; Gåfvels M; Kozarsky KF; Chappell DA; Strauss JF; Strickland DK
J Biol Chem; 1995 Nov; 270(44):26550-7. PubMed ID: 7592875
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
Cianflone K; Avramoglu RK; Sawyez C; Huff MW
Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
[TBL] [Abstract][Full Text] [Related]
14. Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells.
Latron Y; Chautan M; Anfosso F; Alessi MC; Nalbone G; Lafont H; Juhan-Vague I
Arterioscler Thromb; 1991; 11(6):1821-9. PubMed ID: 1931884
[TBL] [Abstract][Full Text] [Related]
15. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
Dichtl W; Ares MP; Stollenwerk M; Giachelli CM; Scatena M; Hamsten A; Eriksson P; Nilsson J
Thromb Haemost; 2000 Oct; 84(4):706-11. PubMed ID: 11057874
[TBL] [Abstract][Full Text] [Related]
16. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation.
Whitman SC; Miller DB; Wolfe BM; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1707-15. PubMed ID: 9327767
[TBL] [Abstract][Full Text] [Related]
17. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.
Gianturco SH; Lin AH; Hwang SL; Young J; Brown SA; Via DP; Bradley WA
J Clin Invest; 1988 Nov; 82(5):1633-43. PubMed ID: 3183059
[TBL] [Abstract][Full Text] [Related]
18. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor.
Nilsson L; Gåfvels M; Musakka L; Ensler K; Strickland DK; Angelin B; Hamsten A; Eriksson P
J Lipid Res; 1999 May; 40(5):913-9. PubMed ID: 10224160
[TBL] [Abstract][Full Text] [Related]
19. Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal cell metabolism.
Sehayek E; Eisenberg S
Arteriosclerosis; 1990; 10(6):1088-96. PubMed ID: 2244857
[TBL] [Abstract][Full Text] [Related]
20. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
